On histopathological examination, nasal polyps and nasal mucosa in allergic rhinitis show different forms of pseudostratifi ed respiratory epithelium, whereas the dominant characteristic of lamina propria is an eosinophilic infi ltration. The aim of this study was to compare interleukin (IL)-5 and eosinophilic cationic protein (ECP) levels in the nasal fl uid of 42 patients: 12 with allergic rhinitis and nasal septal deviation, 17 non-atopic patients with nasal polyposis, and 13 atopic nasal polyp patients were enrolled in this crosssectional study. Nasal secretion samples were collected a few days before surgery. The levels of IL-5 were measured using fl ow cytometry and the ECP using a commercial ELISA kit. In addition, we counted eosinophils in hematoxylin-and-eosin-stained sections of all nasal polyp and all nasal mucosa samples taken from the inferior nasal turbinates during septoplasty. A signifi cantly higher concentration of IL-5 was found in the nasal fl uid of atopic patients with nasal polyposis than in non-atopic nasal polyp patients (p=0.025) and patients with allergic rhinitis (p=0.05). ECP was higher in atopic nasal polyp patients than in patients with allergic rhinitis (p<0.0001) and than in non-atopic nasal polyp patients (p<0.0001). Polyp eosinophils were higher in atopic' than in non-atopic patients (p<0.0001) and higher than in the mucosa of patients with allergic rhinitis (p<0.0001). These however had signifi cantly more mucosal eosinophils than was found in the polyps of non-atopic patients' (p=0.025). ECP levels in nasal fl uid and eosinophil counts in tissue specimens correlated well in all three groups of patients. Our study has shown that atopic nasal polyp patients have a higher level of eosinophilic infl ammation than non-atopic patients with nasal polyps and patients with allergic rhinitis. Arh Hig Rada Tokiskol 2011;62:341-348 Allergic rhinitis is the most common atopic disease in the human population as it affects one in four people worldwide (1, 2). Its prevalence in the European countries ranges between 15 % and 25 %, with a tendency to rise by about 3.5 % with every decade (3). It is a type I allergic reaction mediated by mast cellbound immunoglobulin E (IgE) with a typical helper T-cell type 2 (Th2) profi le (3).
Allergic rhinitis is the most common atopic disease in the human population as it affects one in four people worldwide (1, 2) . Its prevalence in the European countries ranges between 15 % and 25 %, with a tendency to rise by about 3.5 % with every decade (3) . It is a type I allergic reaction mediated by mast cellbound immunoglobulin E (IgE) with a typical helper T-cell type 2 (Th2) profi le (3) . Nasal polyposis is characterised by the proliferation of pseudostratifi ed respiratory epithelium, thickening of the basement membrane, oedema, proliferation of fi broblasts, focal fi brosis, and infl ammatory infi ltration of the lamina propria (4) . The stromal layer of the polyp tissue includes mixed infl ammatory cells. The predominant histological form of nasal polyposis is the eosinophilic type, with an incidence of about 90 % (5). The non-eosinophilic form of nasal polyps is much less common and the dominant cells in the stroma are lymphocytes and plasmocytes (5) . Polyps usually originate from the anterior ethmoid sinus and descend into the nasal cavity through the middle meatus, causing symptoms such as nasal obstruction, anosmia, sneezing, rhinorrhoea, and itching (4) . The aetiology of nasal polyposis is not well known, but may involve several potential factors such as chronic persistent inflammation and oxidative stress. Inflammation triggers include bacterial, fungal and viral infection, allergy, and environmental pollution (6, 7) . Ramanathan et al. (8) suggest that increased presence of eosinophils is associated with ineffective local T helper (Th) 1-based immune response (8) . Weakened Th1 response in nasal polyp patients may follow the down-regulation of specific toll-like receptors (TLR) involved in immune response. Nasal polyposis, which affects about 2.7 % of the European adult population, usually manifests itself after the age of 20 years (7).
Nasal secretion is the fi rst line of nasal mucosa defence (9) . It contains small amounts of cytokines and other inflammatory mediators, produced by epithelial and immunocompetent cells. These peptides are involved in the regulation of infl ammation and immune defence.
Tissue eosinophilia is the general characteristic of allergic rhinitis and of 80 % to 90 % of nasal polyps. Activated eosinophils produce and secrete different vasoactive substances, cytokines, chemotactic factors, leukotrienes, major basic proteins, eosinophilic cationic protein (ECP), and eosinophilic peroxidases (EPOs). Kramer et al. (3) suggest that ECP concentration reflects eosinophil count and the degree of infl ammation.
Interleukin (IL)-5 is a Th2 cytokine that strongly affects the differentiation, proliferation, chemotactic properties, recruitment into the tissue, and survival of eosinophils (3, 4) .
The aims of this cross-sectional study were: (a) to compare the IL-5 and ECP levels detected in nasal fl uid of patients with allergic rhinitis, non-atopic, and atopic patients with nasal polyposis; (b) to compare the eosinophil counts in the nasal mucosa of patients with allergic rhinitis, nasal polyp tissue of non-allergic, and in nasal polyp tissue of allergic patients; and (c) to see if there is any correlation between the infl ammatory mediator levels in nasal secretions and eosinophil count in the infl amed tissues.
METHODS

Patients
The study included forty-two (n=42) patients, 12 with allergic rhinitis and septal deviation, 17 nonatopic patients and 13 atopic patients with bilateral nasal polyposis and indications for surgical treatment. All procedures were performed according to the Helsinki Declaration. All patients gave their written informed consent for participating in the study. The study was approved by the Research Ethics Committee of the Military Medical Academy, Belgrade, Serbia. The diagnosis of bilateral nasal polyposis was based on documented medical history and on the results of anterior rhinoscopy, nasal endoscopy, and computed tomography (CT), according to the current European Guidelines (10) .
The diagnosis of allergic rhinitis followed the guidelines provided by the Allergic Rhinitis and its Impact on Asthma (ARIA) initiative (1, 11) . It was based on the rhinoscopic/endoscopic fi ndings, on the positive skin-prick test to commonly inhaled allergens, on the presence of symptoms including sneezing, nasal itching, nasal congestion/obstruction, rhinorrhoea, and/or red and tearing eyes for the last a month (1, 11) .
The exclusion criteria were: antrochoanal polyps, bronchial asthma, aspirin sensitivity, cystic fi brosis, history of acute respiratory tract infection or treatment with oral and topical corticosteroids, antibiotics and antihistamines for at least three weeks before enrolment, smoking, systemic illness and nasal/sinus surgery for at least six months before the start of the study.
Allergy determination
The exact atopic status was evaluated in all nasal polyp and rhinitis patients on the basis of clinical criteria, medical history of allergy, positive skin-prick test, and positive serological test. Skin-prick tests were performed on the volar part of the forearm with a standard battery of common aeroallergens (Soluprick, Multi test, Alk-Abello, Denmark) including birch, timothy, mugwort (Artemisia vulgaris), dog, cat, horse, mite (Dermatophagoides farinae, Dermatophagoides pteronyssinus), moulds (Alternaria alternata, Aspergillus fumigatus, Cladosporium herbarum), olive tree, spreading pellitory (Parietaria judaica), ribwort plantain (Plantago lanceolata), and London planetree (Platanus acerifolia). Skin-prick testing also included negative (0.9 % natriumchloridum solution) and positive (1 mg mL -1 histamine dihydrochloride solution) controls. Reactions were read after 15 min, as follows (12): 0 -negative, erythema only or no reaction; + -wheal <3 mm; ++ -wheal 3 to 5 mm with fl are; +++ -wheal >5 mm to 7 mm with fl are; ++++ -wheal >7 mm usually with pseudopods and flare. Allergy was diagnosed in patients with a wheal diameter at least 3 mm larger than that of the negative control, regardless of the allergen.
Total serum IgE level was measured using the ELISA kit (Elitech Diagnostics, Salon-de-Provence, France) and an ELISA reader (Spectra III, Austria). Venous blood was collected and centrifuged, and the serum stored at -70 °C until testing. Total serum IgE levels ≥160 IU mL -1 were considered abnormal (13) .
Sampling of nasal secretions and determination of IL-5 and ECP
Nasal fl uid samples were collected from the nasal cavities of all 42 subjects using a modifi ed absorption method (14-16) a few days before surgery. As baseline nasal secretion can be scarce in healthy subjects, control samples were not taken. All cotton-wool sticks with samples were placed in a 2 mL Eppendorf tube containing 1 mL of transfer medium (phosphatebuffered saline with gentamycin 50 μg mL -1 , penicillin G 340 U mL -1 , and fungizone 500 μg mL -1 ) for 30 min to allow for mediators to diffuse into the medium, and were then stored at 4 °C for a maximum of 2 h. Nasal secretion samples were centrifuged at 1000xg for 10 minutes to separate cellular components. After that, supernatants were stored at -70 °C until mediator determination. The concentrations of proinfl ammatory Th2 cytokine IL-5 were determined in each of the 42 samples using a commercial fl ow cytometric kit (Flow Cytomix, Bender MedSystems, USA) on the cytofl uorimeter (Beckman Coulter XL-MCL, USA) according to the manufacturer's instructions. The sensitivity of IL-5 detection was 30 pg mL -1 . The amount of ECP in the nasal fl uid was measured by fluoroimmunoassay (FEIA, UniCAPTM100, Pharmacia Diagnostics AB, Uppsala, Sweden), whose detection limit was 2 μg L -1 .
Tissue preparation and quantifi cation of eosinophils
All the patients were operated on by the same surgeon under general anaesthesia. In the allergic rhinitis group, nasal mucosa samples were taken from the inferior turbinates from patients undergoing septoplasty. Nasal polyps located in the middle meatus were surgically removed. For histological examination, nasal mucosa/polyp samples were fixed in 10 % formaldehyde, embedded in paraffi n, cut with the microtome into 5-μm sections, and stained with haematoxylin and eosin. Histological examination was performed using a digital optical microscope (Nikon Coolscope, Japan) and a computerised picture analysis system. This system was programmed by Image J (Java-based image processing program), as described elsewhere (17) . Once the glass slide was set, brightfi eld images could be viewed on the monitor. The visual field was oriented along the whole length of the epithelium basement membrane. Eosinophils were counted in the surface layer of the mucosa at x400 magnification. The surface layer included the pseudostratifi ed respiratory epithelium up to 0.20 mm below the basal membrane. The rest of the tissue was considered the stromal layer. To yield the mean number of eosinophils per high power fi eld (HPF), 10 randomly chosen HPFs of a single section were examined. We counted the eosinophils in the surface layer in each section and calculated the average number of eosinophils per HPF.
Statistical analysis
Data are expressed as means±standard deviation (±SD). A one-way analysis of variance (ANOVA) was used to calculate the differences between the three groups of patients. We used a post-hoc DunnBonferroni correction to assess the level of statistical difference. A p value of 0.05 and less was considered statistically signifi cant. Correlations between IL-5/ ECP levels in nasal secretions and eosinophil counts in the nasal polyp/nasal mucosa tissue were evaluated using the Pearson's correlation test. For all statistical analysis we used the Stat Plus 2007 programme. Table 1 shows patient group profi les and skin-prick and total serum IgE fi ndings. All patients with allergic rhinitis and atopic nasal polyposis were positive to the skin-prick test and had increased serum IgE. Table 2 shows mediator levels in nasal secretion. The mean IL-5 level was signifi cantly higher in atopic patients with nasal polyposis than in non-atopic patients and in patients with allergic rhinitis.
RESULTS
The mean level of ECP was signifi cantly higher in atopic nasal polyposis patients than in non-atopic patients and patients with allergic rhinitis.
Similarly, eosinophil count in atopic patients was significantly higher than in non-atopic patients (55.92±5.82 vs. 11.12±2.03, p<0.0001) and patients with allergic rhinitis (55.92±5.82 vs. 16.83±7.89, p<0.0001). A signifi cant difference was also found between patients with allergic rhinitis and non-atopic patients (16.83±7.89 vs. 11.12±2.03, p=0.025) ( Table  3) .
Histology seems to confi rm the above fi ndings. Figures 1 and 2 show plenty of eosinophils in the samples taken from patients with allergic rhinitis and atopic nasal polyposis patients, while in non-atopic patients eosinophil infi ltration was scarce (Figure 3) .
We found no statistically signifi cant correlation between IL-5 levels in nasal secretions and eosinophil counts. However, the correlation was positive between the ECP and eosinophil counts in non-atopic nasal polyposis patients and patients with allergic rhinitis (Table 4) . 
DISCUSSION
The prevalence of allergic rhinitis and asthma has been increasing in many countries around the world (1, 11) . Studies vary in reporting the incidence of allergy in patients with nasal polyps. Several authors found little association between allergy and nasal polyps (18) (19) (20) . In contrast, Bachert et al. (21) suggested an association between allergic reaction in the infl amed nasal mucosa and increased total and specifi c IgE in polyps, without systemic manifestation of allergy. Klossek et al. (22) found that allergy was signifi cantly more frequent in the nasal polyp patient group than in the control group (27.1 % vs. 11.9 %, respectively). Asero et al. (23) found that 55 % of nasal polyp patients had a positive skin prick test to at least one allergen. Jovićević and Kljajić (24) found that about 30 % of patients with allergic rhinitis had nasal polyposis. Finally, Muñoz del Castillo et al. (25) demonstrated a positive skin prick test in 63.2 % of 190 nasal polyp patients. However, the relationship between nasal polyposis and allergy remains unclear.
Our study has shown signifi cantly higher IL-5 levels in the nasal secretions of patients with nasal polyposis and allergy than in non-atopic nasal polyposis patients. IL-5 seems to play an important role in the pathogenesis of allergic rhinitis and nasal polyposis, as activates and mobilises eosinophils, and stimulates differentiation and growth of B lymphocytes (26) . Infi ltration and activation of eosinophils are the hallmark of nasal polyp tissue (4, 26) . Findings presented by Fan et al. (4) suggest that T-cell-secreted IL-5 and autosecretion of IL-5 from activated eosinophils may be the reasons for persistent and growing eosinophil infl ammation in the nasal polyp tissue. Activated eosinophils release plenty of cytotoxic proteins and transforming growth factors that cause epithelial injury, basement membrane thickening, glandular hyperplasia, stromal fi brosis, and angiogenesis (4, 26) . Saitoh et al. (27) found a significant correlation in eosinophilic infiltration between the epithelium and lamina propria. Therefore, it is likely that eosinophils migrating into the epithelium continue to secrete cytotoxic mediators and eventually directly add to the epithelial damage. Furthermore, the correlation between eosinophilic infi ltration in the epithelium and epithelial damage was higher than that between eosinophilic infi ltration of the lamina propria and epithelial damage, which suggests that epithelial eosinophils may contribute much more to an aggressive model of nasal polyposis (27) .
Our study has shown higher levels of IL-5 and ECP in the nasal fl uid of atopic patients with nasal polyposis than in patients with allergic rhinitis or non-atopic nasal polyposis. Eosinophil count was about three times as high as in atopic patient polyps as in the nasal mucosa of patients with allergic rhinitis, and about four times as high as in non-atopic patient polyps. This is in accordance with results presented by Cheng et al. (28) .
We also found a positive correlation between the ECP levels in nasal fl uid and eosinophil counts in all three groups of patients, but this correlation was not signifi cant in the atopic nasal polyposis patients. While ECP is toxic to pathogens, helminth in particular, it can also damage airway epithelial cells, elicit local oedema, and produce airway hyperreactivity in asthma and allergic rhinitis patients (29) . It is used as a (31) found that ECP levels were signifi cantly higher in nasal secretions than in the serum and are better connected to disease activity and prefer ECP determination in nasal fl uid over serum to assess the severity of upper airway infl ammation (31) . Sun et al. (32) demonstrated that ECP levels in the nasal fluid of patients with nasal polyposis correlated with asthma and aspirin intolerance. To conclude, allergic nasal polyposis patients in our study showed a higher level of eosinophilic infl ammation than non-allergic patients with nasal polyps or patients with allergic rhinitis. ECP levels in nasal fluid correlated well with the number of eosinophils and could be useful in evaluating the degree of infl ammation in patients with allergic rhinitis and in patients with nasal polyposis.
